Skip to main content

ADVERTISEMENT

cetixumab

Research in Review
03/03/2017
JCP Editors
Adding cetuximab to chemoradiation for squamous cell carcinoma of the anal canal is associated with lower incidence of locoregional failure but high toxicity, according to the results of a study published in the...
Adding cetuximab to chemoradiation for squamous cell carcinoma of the anal canal is associated with lower incidence of locoregional failure but high toxicity, according to the results of a study published in the...
Adding...
03/03/2017
Journal of Clinical Pathways